{
    "medicine_id": "d47020e01dac33423f4e831087fe158d944918e6",
    "platform_id": "DB05210",
    "metadata": {
        "name": "Pretomanid 200 mg 1 Tablet",
        "composition": "200 mg 1 SF1126",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of various forms of cancer",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "SF1126 is a covalent conjugate of LY294002 that contains a peptide based targeting group to help increase the localization of the drug in the neovascular component supporting tumor growth SF1126 is a highly water soluble solid which aids its administration via i v or s c injections In vivo it converts spontaneously at physiological pH to LY294002 in a way that is well tolerated in mice rats and dogs SF1126 has been evaluated in numerous animal tumor models showing good tumor inhibition or tumor regression",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}